This website uses cookies

This websites contains videos from YouTube. This company uses cookies (third party cookies). If you do not want them to use these cookies, you can indicate so here. However, this does mean that you will not be able to watch videos on this website. We also make use of our own cookies in order to improve our website. We don't share our data with other parties. Which cookies are involved?

This website uses cookies to enable video and to improve the user experience. If you do not want to accept these cookies, indicate so here. Which cookies are involved?

Ga direct naar de inhoud, het hoofdmenu, het servicemenu of het zoekveld.


17Apr 2020

Back to Seminars overview

NKI seminar by Reuven Agami

Reuven Agami
Netherlands Cancer Institute, Amsterdam, The Netherlands

The art of genetic screening:
From deregulated transcription to faulty protein production in cancer

Friday, April 17, 2020, 11:00 hours

Piet Borst Auditorium, Netherlands Cancer Institute, Amsterdam


Reuven Agami
Reuven Agami is heading the Division of Oncogenomics at the Netherlands Cancer Institute, and a professor of Molecular Genetics at the University of Rotterdam. Also, he is a member of the Oncode Institute. His laboratory develops genetic tools and novel functional genetic strategies to interrogate cellular processes related to gene expression and regulation in cancer.

Share this page